About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The clinical and basic research activity of the Ophthalmology Research Group is dedicated to finding new treatments for blindness through the development of new therapies for macular and retinal degenerative diseases, as well as for retinal vascular diseases (diabetic retinopathy and retinal vascular occlusions). Our group consists of core researchers and clinical researchers, so there is a clear clinical translation of the ongoing research in the research group.
We have a research program for the development of new therapeutic strategies based on:
In the clinical part, the research group bases its activity on clinical trials to develop new treatments for retinal diseases as well as on the ophthalmic involvement of systemic treatments, an example is the phase II trial to test mesenchymal cells (MSV) intravitreal in non-arteritic ischemic optic neuropathy (NAION), the RECOGNISED study or the PULSAR study with aflibercept.
PMID: 33388189 Journal: JOURNAL FRANCAIS D OPHTALMOLOGIE Year: 2021 Reference: J Fr Ophtalmol. 2021 Apr;44(4):618-619. doi: 10.1016/j.jfo.2020.07.006. Epub 2020 Dec 30. Impact factor: 0.818 Publication type: Letter or abstract Authors: Azarfane, B, Puig, J, Jurado, E, Kirkegaard, E, Berges, M et al. DOI: 10.1016/j.jfo.2020.07.006
PMID: 32301031 Journal: Sleep and Breathing Year: 2021 Reference: Sleep Breath. 2021 Mar;25(1):163-169. doi: 10.1007/s11325-020-02019-y. Epub 2020 Apr 16. Impact factor: 2.816 Publication type: Paper in international publication Authors: Catala-Mora, Jaume, Anton, Alfonso, Perez-Hoyos, Santiago, Carceller, Amadeu, Aparicio, Gloria, Castany-Aregall, Marta, Grau, Nuria et al. DOI: 10.1007/s11325-020-02019-y
PMID: 33738324 Journal: Molecular Therapy-Methods & Clinical Development Year: 2021 Reference: Mol Ther Methods Clin Dev. 2021 Feb 10;20:688-702. doi: 10.1016/j.omtm.2021.02.006. eCollection 2021 Mar 12. Impact factor: 6.698 Publication type: Paper in international publication Authors: Garcia-Arumi, Jose, Veiga, Anna, Zapata, Miguel Angel, Salas, Anna, Duarri, Anna, Fontrodona, Laura, Ramirez, Diana Mora, Badia, Anna, Isla-Magrane, Helena, Ferreira-de-Souza, Barbara et al. DOI: 10.1016/j.omtm.2021.02.006
PMID: 33720541 Journal: ACTA OPHTHALMOLOGICA Year: 2021 Reference: Acta Ophthalmol. 2021 Dec;99(8):861-870. doi: 10.1111/aos.14786. Epub 2021 Mar 15. Impact factor: 3.761 Publication type: Paper in international publication Authors: Galvez, Maria Isabel Lopez, Saenz-de-Viteri, Manuel, Recalde, Sergio, Fernandez-Robredo, Patricia, Lopez Galvez, Maria Isabel, Arias Barquet, Lluis, Figueroa, Marta S, Garcia-Arumi, Jose, Garcia-Layana, Alfredo, Figueroa, Marta S et al. DOI: 10.1111/aos.14786
PMID: 32344735 Journal: Journal of Clinical Medicine Year: 2020 Reference: J Clin Med. 2020 Apr 24;9(4). pii: jcm9041233. doi: 10.3390/jcm9041233. Impact factor: 3.303 Publication type: Paper in international publication Authors: Egan, Catherine, Hernandez, Cristina, Porta, Massimo, Bandello, Francesco, Grauslund, Jakob, Harding, Simon P, Aldington, Stephen J, Gibson, Jonathan, Lang, Gabriele E, Lattanzio, Rosangela et al. DOI: 10.3390/jcm9041233
PMID: 32349099 Journal: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES Year: 2020 Reference: Retina. 2020 Aug;40(8):e38-e39. doi: 10.1097/IAE.0000000000002832. Impact factor: 3.649 Publication type: Letter or abstract Authors: Copete, Sergio, Pastor-Idoate, Salvador, Garcia-Arumi, Josep, Zapata, Miguel A et al. DOI: 10.1097/IAE.0000000000002832
PMID: 32190990 Journal: ACTA OPHTHALMOLOGICA Year: 2020 Reference: Acta Ophthalmol. 2020 Nov;98(7):e820-e829. doi: 10.1111/aos.14399. Epub 2020 Mar 19. Impact factor: 3.362 Publication type: Paper in international publication Authors: S Figueroa, Marta, Garcia-Layana, Alfredo, Ruiz Moreno, Jose M, Fernandez Rodriguez, Maribel, Garcia Arumi, Josep, Amat Peral, Pedro, Ascaso Puyuelo, Javier, Armada Maresca, Felix, Cervera Taulet, Enrique, Torres Imaz, Ramon et al. DOI: 10.1111/aos.14399
PMID: 31972792 Journal: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES Year: 2020 Reference: Retina. 2020 Feb;40(2):233-240. doi: 10.1097/IAE.0000000000002368. Impact factor: 3.649 Publication type: Paper in international publication Authors: Bove Alvarez, Maria, Sabate, Sergi, Gomez-Resa, Maria, Garcia-Arumi, Jose et al. DOI: 10.1097/IAE.0000000000002368
PMID: 30295076 Journal: EUROPEAN JOURNAL OF OPHTHALMOLOGY Year: 2019 Reference: Eur J Ophthalmol. 2019 Nov;29(6):664-672. doi: 10.1177/1120672118804079. Epub 2018 Oct 7. Impact factor: 1.716 Publication type: Paper in international publication Authors: , Abreu-Gonzalez, Rodrigo, Gallego-Pinazo, Roberto, Abraldes, Maximino, Pinilla, Isabel, Lopez-Galvez, Maria I, , , , Boixadera Espax, Ana et al. DOI: 10.1177/1120672118804079
PMID: 30157113 Journal: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES Year: 2019 Reference: Retina. 2019 Nov;39(11):2225-2232. doi: 10.1097/IAE.0000000000002298. Impact factor: 3.815 Publication type: Paper in international publication Authors: Marti-Rodrigo, Pablo, Copete, Sergio, Rigo, Jaume, Figueroa, Marta S, Garcia-Arumi, Jose, Zapata, Miguel A, Pastor-Idoate, Salvador, Muniz-Vidal, Romina et al. DOI: 10.1097/IAE.0000000000002298
PMID: 31582183 Journal: Archivos de la Sociedad Espanola de Oftalmologia Year: 2019 Reference: Arch Soc Esp Oftalmol. 2019 Dec;94(12):585-590. doi: 10.1016/j.oftal.2019.05.019. Epub 2019 Oct 1. Impact factor: 0 Publication type: Paper in national publication Authors: Martin Begue, N, Puig Galy, J, Velazquez Villoria, D, Arcos Algaba, G, Mora Ramirez, D, Garcia-Arumi, J, Lagreze, W A, Galan Terraza, A, Velez Escola, L et al. DOI: 10.1016/j.oftal.2019.05.019
PMID: 31451909 Journal: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY Year: 2019 Reference: Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2381-2390. doi: 10.1007/s00417-019-04446-4. Epub 2019 Aug 26. Impact factor: 2.25 Publication type: Paper in international publication Authors: Fonollosa, Alejandro, Zarranz-Ventura, Javier, Valverde, Alicia, Becerra, Erika, Bernal-Morales, Carolina, Pastor-Idoate, Salvador, Zapata, Miguel Angel et al. DOI: 10.1007/s00417-019-04446-4
On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.
Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.
Dr. José García Arumi and Dr. Anna Duarri from the Ophthalmology research group at Vall Hebron Recerca lead the project.
